CUSIP: 686164AC8
What is CUSIP 686164AC8?
CUSIP 686164AC8 identifies 686164AC8 - OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 686164AC8:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2018 Q2 | $0 | $0 | -$236,000 | 0 | |
| 2018 Q1 | $3,378,000 | $236,000 | -$12,134,000 | 6.99% | 1 |
| 2017 Q4 | $38,289,000 | $13,265,000 | -$556,172 | 34.3% | 7 |
| 2017 Q3 | $39,789,000 | $16,143,000 | -$730,860 | 40.07% | 7 |
| 2017 Q2 | $41,789,000 | $19,095,000 | -$101,375 | 47.01% | 7 |
| 2017 Q1 | $41,989,000 | $20,618,000 | +$20,618,000 | 49.73% | 7 |